JPS58215557A - 潜血テスト方法 - Google Patents
潜血テスト方法Info
- Publication number
- JPS58215557A JPS58215557A JP58093292A JP9329283A JPS58215557A JP S58215557 A JPS58215557 A JP S58215557A JP 58093292 A JP58093292 A JP 58093292A JP 9329283 A JP9329283 A JP 9329283A JP S58215557 A JPS58215557 A JP S58215557A
- Authority
- JP
- Japan
- Prior art keywords
- guaiac
- acid
- substrate
- slide
- buffered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims description 27
- 238000009534 blood test Methods 0.000 title 1
- 241000147041 Guaiacum officinale Species 0.000 claims abstract description 36
- 229940091561 guaiac Drugs 0.000 claims abstract description 36
- 239000002253 acid Substances 0.000 claims abstract description 16
- 239000008280 blood Substances 0.000 claims abstract description 15
- 210000004369 blood Anatomy 0.000 claims abstract description 15
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 13
- 239000002250 absorbent Substances 0.000 claims abstract description 7
- 230000002745 absorbent Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 210000004051 gastric juice Anatomy 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229940069078 citric acid / sodium citrate Drugs 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 10
- 230000002496 gastric effect Effects 0.000 abstract description 9
- 239000012530 fluid Substances 0.000 abstract description 6
- 239000008366 buffered solution Substances 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 description 9
- 108010054147 Hemoglobins Proteins 0.000 description 9
- 102000003992 Peroxidases Human genes 0.000 description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 description 8
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 7
- 229960001380 cimetidine Drugs 0.000 description 7
- 239000000872 buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010038460 Renal haemorrhage Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000003423 Mucocele Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- -1 aspirin Chemical compound 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- POSZUTFLHGNLHX-KSBRXOFISA-N tris maleate Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO.OC(=O)\C=C/C(O)=O POSZUTFLHGNLHX-KSBRXOFISA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/726—Devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38290882A | 1982-05-28 | 1982-05-28 | |
| US382908 | 1982-05-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58215557A true JPS58215557A (ja) | 1983-12-15 |
| JPH0449656B2 JPH0449656B2 (enExample) | 1992-08-12 |
Family
ID=23510927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58093292A Granted JPS58215557A (ja) | 1982-05-28 | 1983-05-25 | 潜血テスト方法 |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0095302B1 (enExample) |
| JP (1) | JPS58215557A (enExample) |
| KR (1) | KR900005485B1 (enExample) |
| AT (1) | ATE18307T1 (enExample) |
| AU (1) | AU557883B2 (enExample) |
| BG (1) | BG42009A3 (enExample) |
| CA (1) | CA1216501A (enExample) |
| CS (1) | CS259514B2 (enExample) |
| DD (1) | DD211874A5 (enExample) |
| DE (1) | DE3362264D1 (enExample) |
| DK (1) | DK159173C (enExample) |
| ES (1) | ES8404513A1 (enExample) |
| FI (1) | FI75436C (enExample) |
| GR (1) | GR79286B (enExample) |
| HU (1) | HU192806B (enExample) |
| IE (1) | IE54507B1 (enExample) |
| IL (1) | IL68767A0 (enExample) |
| NO (1) | NO161196C (enExample) |
| NZ (1) | NZ204343A (enExample) |
| PH (1) | PH23572A (enExample) |
| PL (1) | PL142241B1 (enExample) |
| PT (1) | PT76748B (enExample) |
| ZA (1) | ZA833856B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6073462A (ja) * | 1983-09-29 | 1985-04-25 | ヘレナ ラボラトリイズ コ−ポレイシヨン | 試験組成物、試験キット及び潜血検出方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3314308A1 (de) * | 1983-04-20 | 1984-10-25 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und reagens zur bestimmung des haemoglobin-haptoglobin komplexes in gegenwart von freiem haemoglobin |
| US5374328A (en) * | 1993-03-25 | 1994-12-20 | Watkins Johnson Company | Method of fabricating group III-V compound |
| CN111273007B (zh) * | 2020-03-13 | 2023-08-01 | 内江师范学院 | 一种用于快速检测鱼类鮰爱德华氏菌的试剂盒及检测方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53127812A (en) * | 1977-04-09 | 1978-11-08 | Boehringer Mannheim Gmbh | Production of guayaconic acid a * diagnostic agent containing same and method for detecting lavent bleeding in excrement |
| JPS5693045A (en) * | 1979-12-10 | 1981-07-28 | Baylor College Medicine | Detection and quantitative determination of occult blood |
| JPS58140643A (ja) * | 1982-01-05 | 1983-08-20 | ヘレナ・ラボラトリーズ・コーポレイシヨン | 家庭用診断助剤および潜血存在の判定法 |
| JPS58196458A (ja) * | 1982-04-30 | 1983-11-15 | ヘレナ・ラボラトリーズ・コーポレイシヨン | 潜血の存在を判定するための診断助剤および方法 |
| JPS6432947A (en) * | 1987-07-30 | 1989-02-02 | Shiroki Corp | Door lock/unlock detecting device for burglary preventing device for automobile |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3933594A (en) * | 1974-08-16 | 1976-01-20 | Polaroid Corporation | Method and device for determining the concentration of a substance in a fluid |
| DE2716060C3 (de) * | 1977-04-09 | 1980-06-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisierte Schnelldiagnostica mit Oxydationsindikatoren |
| AT360176B (de) * | 1977-07-01 | 1980-12-29 | Roehm Gmbh | Testkarte fuer den nachweis okkulten bluts im stuhl |
| US4175923A (en) * | 1978-06-26 | 1979-11-27 | Friend William G | Method and apparatus for occult blood testing in the home |
-
1982
- 1982-05-25 PH PH28955A patent/PH23572A/en unknown
-
1983
- 1983-05-17 DE DE8383302770T patent/DE3362264D1/de not_active Expired
- 1983-05-17 EP EP83302770A patent/EP0095302B1/en not_active Expired
- 1983-05-17 AT AT83302770T patent/ATE18307T1/de not_active IP Right Cessation
- 1983-05-23 IL IL68767A patent/IL68767A0/xx unknown
- 1983-05-24 PT PT76748A patent/PT76748B/pt unknown
- 1983-05-24 DK DK231083A patent/DK159173C/da not_active IP Right Cessation
- 1983-05-24 FI FI831850A patent/FI75436C/fi not_active IP Right Cessation
- 1983-05-24 CA CA000428695A patent/CA1216501A/en not_active Expired
- 1983-05-24 NZ NZ204343A patent/NZ204343A/en unknown
- 1983-05-24 GR GR71446A patent/GR79286B/el unknown
- 1983-05-25 JP JP58093292A patent/JPS58215557A/ja active Granted
- 1983-05-25 AU AU14976/83A patent/AU557883B2/en not_active Ceased
- 1983-05-25 KR KR1019830002290A patent/KR900005485B1/ko not_active Expired
- 1983-05-26 CS CS833802A patent/CS259514B2/cs unknown
- 1983-05-26 ES ES522738A patent/ES8404513A1/es not_active Expired
- 1983-05-26 NO NO831871A patent/NO161196C/no unknown
- 1983-05-26 BG BG061091A patent/BG42009A3/xx unknown
- 1983-05-26 PL PL1983242217A patent/PL142241B1/pl unknown
- 1983-05-27 IE IE1262/83A patent/IE54507B1/en unknown
- 1983-05-27 ZA ZA833856A patent/ZA833856B/xx unknown
- 1983-05-27 HU HU831892A patent/HU192806B/hu unknown
- 1983-05-27 DD DD83251341A patent/DD211874A5/de not_active IP Right Cessation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53127812A (en) * | 1977-04-09 | 1978-11-08 | Boehringer Mannheim Gmbh | Production of guayaconic acid a * diagnostic agent containing same and method for detecting lavent bleeding in excrement |
| JPS5693045A (en) * | 1979-12-10 | 1981-07-28 | Baylor College Medicine | Detection and quantitative determination of occult blood |
| JPS58140643A (ja) * | 1982-01-05 | 1983-08-20 | ヘレナ・ラボラトリーズ・コーポレイシヨン | 家庭用診断助剤および潜血存在の判定法 |
| JPS58196458A (ja) * | 1982-04-30 | 1983-11-15 | ヘレナ・ラボラトリーズ・コーポレイシヨン | 潜血の存在を判定するための診断助剤および方法 |
| JPS6432947A (en) * | 1987-07-30 | 1989-02-02 | Shiroki Corp | Door lock/unlock detecting device for burglary preventing device for automobile |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6073462A (ja) * | 1983-09-29 | 1985-04-25 | ヘレナ ラボラトリイズ コ−ポレイシヨン | 試験組成物、試験キット及び潜血検出方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4486536A (en) | Specimen slide for occult blood testing | |
| US4333734A (en) | Diagnostic device for fecal occult blood and method of use | |
| US4541987A (en) | Test pad for detecting occult blood | |
| EP0037056B1 (de) | Verfahren und diagnostische Mittel zum Nachweis von Redox-Reaktionen | |
| US4742002A (en) | Test kit and method for determining the presence of blood in a specimen and for testing the effectiveness of peroxidase inactivating solution | |
| US3598704A (en) | Diagnostic device for various sugars | |
| EP0222700B1 (en) | Composition and method for determining peroxidase-like activity of hemoglobin | |
| JPH04237500A (ja) | ケトン体の検定のための組成物及び方法 | |
| JPS6322260B2 (enExample) | ||
| US5273888A (en) | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals | |
| US4725553A (en) | Test composition for detecting occult blood | |
| JPS62240861A (ja) | 潜血試験モニタ− | |
| JPH0595797A (ja) | 基本媒体用ペルオキシダーゼ指示薬を用いる分析方法及び分析具 | |
| JPS58215557A (ja) | 潜血テスト方法 | |
| JP2000214169A (ja) | 改良されたクレアチニン検出検査 | |
| US4676950A (en) | Indicator and test device for detecting occult blood | |
| JPH05260994A (ja) | ペルオキシド−ペルオキシダーゼ試験系を使用する唾液中の被検体の検出法 | |
| NO742419L (enExample) | ||
| AU655509B2 (en) | Use of polymer-copper complex to control interference of biological substances in colorimetric test systems | |
| CN118275668B (zh) | 一种大便隐血测试卡的制备及其使用方法 | |
| JPS584916B2 (ja) | 試料中の尿酸を測定するための試験手段 | |
| EP0348144A2 (en) | Method for treating mucus-containing immunoassay samples | |
| Liu et al. | Positive interference of catecholamine metabolites with quantitation of urinary uric acid by the direct acid ferric-reduction method. | |
| US6875614B2 (en) | Occult blood test enhancer | |
| JPH0566120B2 (enExample) |